What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?

What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?

What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jonathan Kay, MD

Jonathan Kay, MD

Director of Clinical Research Rheumatology Division Professor of Medicine University of Massachusetts Medical School Worcester, MA